Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2014

Open Access 01-12-2014 | Research

Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary

Authors: Leah Kleinman, Sally Mannix, Lesley M Arnold, Claire Burbridge, Kellee Howard, Kelly McQuarrie, Verne Pitman, Malca Resnick, Tom Roth, Tara Symonds

Published in: Health and Quality of Life Outcomes | Issue 1/2014

Login to get access

Abstract

Objectives

Sleep disturbance is a common experience in fibromyalgia (FM). The field lacks a sleep specific patient reported outcome (PRO) measure developed and validated in a FM population. The study objective is to gain an in-depth understanding of sleep in FM and to develop a PRO measure of it.

Methods

Research involved the following stages: 1) A literature review conducted to identify key concepts associated with FM patient experience of sleep and PRO measures that have been used to assess this; 2) Qualitative interviews with therapeutic area experts; 3) Focus groups with FM patients who experienced sleep disturbance; 4) Development of a conceptual framework and the Fibromyalgia Sleep Diary (FMSD); and 5) Cognitive interviews with patients to explore content validity of the FMSD.

Results

The literature review and expert interviews supported sleep disturbance being an important aspect of the FM patient experience, and underscored the need for a new FM specific sleep PRO measure. Results from the focus groups demonstrated that FM patients experience sleep disturbances that they attribute to their FM symptoms, such as pain and stiffness, confirming the importance of understanding more about sleep changes. Aspects of sleep raised by FM patients included poor sleep quality and insufficient quantity including difficulty with falling asleep, getting comfortable, and staying asleep; restlessness; light sleep; not feeling rested upon awakening; and difficulty starting the day. Cognitive interview results showed that the 8-item FMSD, developed to reflect the concepts identified above, was relevant to FM patients with content that was interpreted as intended.

Conclusions

The FMSD was developed in line with the recommendations of the FDA PRO guidance and ISPOR PRO Task Force. The qualitative evidence generated thus far strongly supports the content validity of the FMSD as a PRO measure of sleep disturbance in FM populations. Psychometric evaluation of the FMSD to demonstrate reliability, validity and sensitivity to change is recommended as a next step.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IK, Sheon RP: The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33: 160–172. 10.1002/art.1780330203CrossRefPubMed Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IK, Sheon RP: The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33: 160–172. 10.1002/art.1780330203CrossRefPubMed
2.
go back to reference Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, Martin SA, Morea J, Simon L, Strand CV, Williams DA, Group OFW: Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol 2009, 36: 2318–2329. 10.3899/jrheum.090367PubMedCentralCrossRefPubMed Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, Martin SA, Morea J, Simon L, Strand CV, Williams DA, Group OFW: Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol 2009, 36: 2318–2329. 10.3899/jrheum.090367PubMedCentralCrossRefPubMed
3.
go back to reference Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, Chappell A, Choy E, Clauw D, Dadabhoy D, Gendreau M, Goldenberg D, Littlejohn G, Martin S, Perera P, Russell IJ, Simon L, Spaeth M, Williams D, Crofford L: Fibromyalgia syndrome. J Rheumatol 2007, 34: 1415–1425.PubMed Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, Chappell A, Choy E, Clauw D, Dadabhoy D, Gendreau M, Goldenberg D, Littlejohn G, Martin S, Perera P, Russell IJ, Simon L, Spaeth M, Williams D, Crofford L: Fibromyalgia syndrome. J Rheumatol 2007, 34: 1415–1425.PubMed
4.
go back to reference Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA: Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 2008, 73: 114–120. 10.1016/j.pec.2008.06.005PubMedCentralCrossRefPubMed Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA: Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 2008, 73: 114–120. 10.1016/j.pec.2008.06.005PubMedCentralCrossRefPubMed
5.
go back to reference Guidance for Industry on Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims Fed Regist 2009, 74: 65132–65133. Guidance for Industry on Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims Fed Regist 2009, 74: 65132–65133.
6.
go back to reference Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L: Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1–eliciting concepts for a new PRO instrument. Value Health 2011, 14: 967–977. 10.1016/j.jval.2011.06.014CrossRefPubMed Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L: Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1–eliciting concepts for a new PRO instrument. Value Health 2011, 14: 967–977. 10.1016/j.jval.2011.06.014CrossRefPubMed
7.
go back to reference Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L: Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2–assessing respondent understanding. Value Health 2011, 14: 978–988. 10.1016/j.jval.2011.06.013CrossRefPubMed Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L: Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2–assessing respondent understanding. Value Health 2011, 14: 978–988. 10.1016/j.jval.2011.06.013CrossRefPubMed
8.
go back to reference Swick TJ, Alvarez-Horine S, Zheng Y, Guinta D, Inhaber N, Holman A, Smith TR, Russell I: Impaired sleep and daytime functioning at baseline in subjects with fibromyalgia from a 14-week randomized, double-blind, placebo-controlled trial of sodium oxybate. Sleep 2009, 32: A330. Swick TJ, Alvarez-Horine S, Zheng Y, Guinta D, Inhaber N, Holman A, Smith TR, Russell I: Impaired sleep and daytime functioning at baseline in subjects with fibromyalgia from a 14-week randomized, double-blind, placebo-controlled trial of sodium oxybate. Sleep 2009, 32: A330.
9.
go back to reference Osorio CD, Gallinaro AL, Lorenzi-Filho G, Lage LV: Sleep quality in patients with fibromyalgia using the Pittsburgh sleep quality index. J Rheumatol 2006, 33: 1863–1865.PubMed Osorio CD, Gallinaro AL, Lorenzi-Filho G, Lage LV: Sleep quality in patients with fibromyalgia using the Pittsburgh sleep quality index. J Rheumatol 2006, 33: 1863–1865.PubMed
10.
go back to reference Cappelleri JC, Bushmakin AG, McDermott AM, Sadosky A, Petrie CD, Martin S: Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia. Sleep 2009, 32: A328. Cappelleri JC, Bushmakin AG, McDermott AM, Sadosky A, Petrie CD, Martin S: Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia. Sleep 2009, 32: A328.
11.
go back to reference Chervin RD, Teodorescu M, Kushwaha R, Deline AM, Brucksch CB, Ribbens-Grimm C, Ruzicka DL, Stein PK, Clauw DJ, Crofford LJ: Objective measures of disordered sleep in fibromyalgia. J Rheumatol 2009, 36: 2009–2016. 10.3899/jrheum.090051PubMedCentralCrossRefPubMed Chervin RD, Teodorescu M, Kushwaha R, Deline AM, Brucksch CB, Ribbens-Grimm C, Ruzicka DL, Stein PK, Clauw DJ, Crofford LJ: Objective measures of disordered sleep in fibromyalgia. J Rheumatol 2009, 36: 2009–2016. 10.3899/jrheum.090051PubMedCentralCrossRefPubMed
12.
go back to reference Campos RMS, Silva A, Monico Neto M, Queiroz S, Antunes HK, Tufik S, de Mello M: Profile level of physical activity and quality of sleep in patients with fibromyalgia. Sleep Med 2009, 10: S44. 10.1016/S1389-9457(09)70163-7CrossRef Campos RMS, Silva A, Monico Neto M, Queiroz S, Antunes HK, Tufik S, de Mello M: Profile level of physical activity and quality of sleep in patients with fibromyalgia. Sleep Med 2009, 10: S44. 10.1016/S1389-9457(09)70163-7CrossRef
13.
go back to reference Moldofsky H: The significance, assessment, and management of nonrestorative sleep in fibromyalgia syndrome. CNS Spectr 2008, 13: 22–26.PubMed Moldofsky H: The significance, assessment, and management of nonrestorative sleep in fibromyalgia syndrome. CNS Spectr 2008, 13: 22–26.PubMed
14.
go back to reference Moldofsky H, Inhaber NH, Guinta DR, Alvarez-Horine SB: Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study. J Rheumatol 2010, 37: 2156–2166. 10.3899/jrheum.091041CrossRefPubMed Moldofsky H, Inhaber NH, Guinta DR, Alvarez-Horine SB: Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study. J Rheumatol 2010, 37: 2156–2166. 10.3899/jrheum.091041CrossRefPubMed
15.
go back to reference Humphrey L, Arbuckle R, Mease P, Williams DA, Samsoe BD, Gilbert C: Fatigue in fibromyalgia: a conceptual model informed by patient interviews. BMC Musculoskelet Disord 2010, 11: 216. 10.1186/1471-2474-11-216PubMedCentralCrossRefPubMed Humphrey L, Arbuckle R, Mease P, Williams DA, Samsoe BD, Gilbert C: Fatigue in fibromyalgia: a conceptual model informed by patient interviews. BMC Musculoskelet Disord 2010, 11: 216. 10.1186/1471-2474-11-216PubMedCentralCrossRefPubMed
16.
go back to reference Martin S, Chandran A, Zografos L, Zlateva G: Evaluation of the impact of fibromyalgia on patients’ sleep and the content validity of two sleep scales. Health Qual Life Outcomes 2009, 7: 64. 10.1186/1477-7525-7-64PubMedCentralCrossRefPubMed Martin S, Chandran A, Zografos L, Zlateva G: Evaluation of the impact of fibromyalgia on patients’ sleep and the content validity of two sleep scales. Health Qual Life Outcomes 2009, 7: 64. 10.1186/1477-7525-7-64PubMedCentralCrossRefPubMed
17.
go back to reference Martinez JE, Cruz CG, Aranda C, Boulos FC, Lagoa LA: Disease perceptions of Brazilian fibromyalgia patients: do they resemble perceptions from other countries? Int J Rehabil Res 2003, 26: 223–227. 10.1097/00004356-200309000-00010CrossRefPubMed Martinez JE, Cruz CG, Aranda C, Boulos FC, Lagoa LA: Disease perceptions of Brazilian fibromyalgia patients: do they resemble perceptions from other countries? Int J Rehabil Res 2003, 26: 223–227. 10.1097/00004356-200309000-00010CrossRefPubMed
18.
go back to reference Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, Simon LS, Strand CV, Bramson C, Martin S, Wright TM, Littman B, Wernicke JF, Gendreau RM, Crofford LJ: Fibromyalgia syndrome. J Rheumatol 2005, 32: 2270–2277.PubMed Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, Simon LS, Strand CV, Bramson C, Martin S, Wright TM, Littman B, Wernicke JF, Gendreau RM, Crofford LJ: Fibromyalgia syndrome. J Rheumatol 2005, 32: 2270–2277.PubMed
19.
go back to reference Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991, 18: 728–733.PubMed Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991, 18: 728–733.PubMed
20.
go back to reference Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28: 193–213. 10.1016/0165-1781(89)90047-4CrossRefPubMed Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28: 193–213. 10.1016/0165-1781(89)90047-4CrossRefPubMed
21.
go back to reference Hays RD, Stewart AL: Sleep measures. In Measuring functioning and well-being: the medical outcomes study approach. Edited by: Stewart AL, Ware JE. Duke University Press, Durham, NC; 1992:235–259. Hays RD, Stewart AL: Sleep measures. In Measuring functioning and well-being: the medical outcomes study approach. Edited by: Stewart AL, Ware JE. Duke University Press, Durham, NC; 1992:235–259.
22.
go back to reference Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14: 540–545.PubMed Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14: 540–545.PubMed
23.
go back to reference Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM: A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988, 41: 313–321. 10.1016/0895-4356(88)90138-2CrossRefPubMed Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM: A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988, 41: 313–321. 10.1016/0895-4356(88)90138-2CrossRefPubMed
24.
go back to reference Smets EM, Garssen B, Bonke B, De Haes JC: The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39: 315–325. 10.1016/0022-3999(94)00125-OCrossRefPubMed Smets EM, Garssen B, Bonke B, De Haes JC: The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39: 315–325. 10.1016/0022-3999(94)00125-OCrossRefPubMed
25.
go back to reference Leidy NK, Vernon M: Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics 2008, 26: 363–370. 10.2165/00019053-200826050-00002CrossRefPubMed Leidy NK, Vernon M: Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics 2008, 26: 363–370. 10.2165/00019053-200826050-00002CrossRefPubMed
Metadata
Title
Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary
Authors
Leah Kleinman
Sally Mannix
Lesley M Arnold
Claire Burbridge
Kellee Howard
Kelly McQuarrie
Verne Pitman
Malca Resnick
Tom Roth
Tara Symonds
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2014
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-014-0111-6

Other articles of this Issue 1/2014

Health and Quality of Life Outcomes 1/2014 Go to the issue